We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
-43.23%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
10 Year Est. Return
AUM
$23.1M
AUM Growth
-$28M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML
1
DELISTED
Tourmaline Bio
TRML
$11.3M 48.83%
741,691
KRRO icon
2
Korro Bio
KRRO
$153M
$6.41M 27.74%
368,085
JSPR icon
3
Jasper Therapeutics
JSPR
$22.9M
$3.99M 17.29%
928,964
HLVX
4
DELISTED
HilleVax
HLVX
$540K 2.34%
372,615
VTYX
5
DELISTED
Ventyx Biosciences
VTYX
$474K 2.05%
412,225
KZR
6
DELISTED
Kezar Life Sciences
KZR
$404K 1.75%
82,871

Similar funds

Qiming U.S. Ventures Management's Q1 2025 Portfolio in Review

As of Q1 2025, Qiming U.S. Ventures Management held 6 positions worth $23.1M, down 55% from $51.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Qiming U.S. Ventures Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $23.1M portfolio in Q1 2025.
  • Qiming U.S. Ventures Management opened 0 new positions and closed 0 in Q1 2025.
  • Qiming U.S. Ventures Management's portfolio value fell 55% quarter-over-quarter to $23.1M.

Based on Qiming U.S. Ventures Management's 13F filing for Q1 2025, filed 15 May 2025.